NMOSD

The NeurologyLive® MS Disease Spotlight page offers specific updates and coverage on the latest expert conversations and data readouts related to the treatment and management of patients with multiple sclerosis and demyelinating disorders.

Latest News

Researchers Identify Distinct Differences in Acute Optic Neuropathy of MOGAD vs Nonarterior Anterior Ischemic Optic Neuropathy
Researchers Identify Distinct Differences in Acute Optic Neuropathy of MOGAD vs Nonarterior Anterior Ischemic Optic Neuropathy

April 23rd 2024

Between those with NMOSD and NAION, the data showed differences in disc edema, peripapillary nerve fiber layer thickening, vision loss, and the symptoms that preceded vision loss.

Treating NMOSD: Where Do We Go After Complement Inhibition's Success?
Treating NMOSD: Where Do We Go After Complement Inhibition's Success?

March 28th 2024

Satralizumab Fails to Reach Expected Clinical Benefit in LUMINESCE Study of Myasthenia Gravis
Satralizumab Fails to Reach Expected Clinical Benefit in LUMINESCE Study of Myasthenia Gravis

March 27th 2024

FDA Approves Alexion's Ravulizumab-cwvz for Neuromyelitis Optica Spectrum Disorder
FDA Approves Alexion's Ravulizumab-cwvz for Neuromyelitis Optica Spectrum Disorder

March 25th 2024

Neuromyelitis Optica Spectrum Disorder Prevalent in Sjogren Syndrome, Meta-Analysis Shows
Neuromyelitis Optica Spectrum Disorder Prevalent in Sjogren Syndrome, Meta-Analysis Shows

March 12th 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.